ANI Pharmaceuticals To Present At The 2026 Jefferies Global Healthcare Conference

(MENAFN- GlobeNewsWire - Nasdaq) PRINCETON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference as follows:

Date:	Wednesday, June 3, 2026
Time:	3:45 p.m. ET
Webcast:	Click Here

The live and archived webcast will be accessible from the Company's website at , under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.

About ANI

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of“Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit

Investor Relations:
Irina Koffler, Vice President, Investor Relations
T: 917-734-7387
E:...

Media Relations:
Argot Partners
T: 212-600-1494
E:...

SOURCE: ANI Pharmaceuticals, Inc.

MENAFN27052026004107003653ID1111173344